Marimed (MRMD) Capital Expenditures Growth (3y) (2017 - 2026)
Marimed (MRMD) Capital Expenditures Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 28.56% |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 44.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.22% |
| Sep 30, 2025 | 5.73% |
| Jun 30, 2025 | 4.55% |
| Mar 31, 2025 | -59.54% |
| Dec 31, 2024 | -61.02% |
| Sep 30, 2024 | -4.66% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 482.96% |
| Dec 31, 2023 | 50.28% |
| Sep 30, 2023 | -4.77% |
| Jun 30, 2023 | 47.44% |
| Mar 31, 2023 | -26.28% |
| Sep 30, 2022 | -26.72% |
| Jun 30, 2022 | -16.54% |
| Mar 31, 2022 | 37.68% |
| Dec 31, 2021 | 120.53% |
| Sep 30, 2021 | -2.04% |
| Jun 30, 2021 | -40.51% |
| Mar 31, 2021 | 35.18% |
| Dec 31, 2020 | -29.77% |